Lauren S. Kramer

Lauren Kramer advises public and private companies, private equity firms, family offices and sovereign wealth funds in U.S. and cross-border acquisitions, divestitures, mergers, carve-outs, strategic investments and corporate governance matters.

Ms. Kramer’s select representations include:

• Honeywell in its:
  • pending $4.95 billion acquisition of the global access solutions business of Carrier Global Corporation
  • $1.3 billion acquisition of Sparta Systems from New Mountain Capital
• Keurig Dr Pepper in its strategic partnership and $300 million investment in La Colombe Coffee Roasters
• Activision Blizzard Inc. in its $75 billion acquisition by Microsoft Corporation
• Genesys, a portfolio company of the Permira Funds and Hellman & Friedman, in a $580 million round of funding at a valuation of $21 billion
• Spotify Technology S.A. in its (i) acquisition of Chartable Holding Inc. and (ii) acquisition of Megaphone LLC from Graham Holdings
• OceanSound Partners and its portfolio company Netrix in the acquisition of the managed IT services business unit of Contegix, LLC
• American Express Global Business Travel in its acquisition of Ovation Travel Group
• Vital Proteins in its acquisition by Nestlé Health Science
• Mubadala Investment Company in its investment as part of a consortium of $2.25 billion in Waymo
• NXP Semiconductors N.V. in its:
  • $1.8 billion acquisition of Marvell Technology Group Ltd.’s wireless connectivity portfolio
  • proposed (but terminated) $47 billion acquisition by Qualcomm Incorporated
• Permira Funds in several transactions, including:
• the sale of its portfolio company LSNE to PCI Pharma Services
• its acquisition of a majority stake in Axiom
• its acquisition of a majority stake in Reformation
• its acquisition of a majority stake in Cielo, Inc. from Accel-KKR
• its acquisition of Evonik Jayhawk Fine Chemicals Corporation from Evonik Industries AG
• the $2.3 billion sale of its portfolio company Atrium Innovations to Nestlé S.A.
• Goldman Sachs & Co. as financial advisor in several transactions, including:
  • Turning Point Therapeutics, Inc. in its $4.1 billion sale to Bristol-Myers Squibb Company
  • Covetrus, Inc. in its $4 billion sale to funds affiliated with Clayton, Dubilier & Rice and TPG Capital
  • American Renal Associates Holdings, Inc. in its $853 million sale to Innovative Renal Care, LLC, an affiliate of Nautic Partners, LLC
  • TRATON SE in its $3.7 billion acquisition of Navistar International Corporation